These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3787710)
1. Cyclosporine and analogues: structural requirements for immunosuppressive activity. Wenger R Transplant Proc; 1986 Dec; 18(6 Suppl 5):213-8. PubMed ID: 3787710 [No Abstract] [Full Text] [Related]
2. Synthesis of ciclosporin and analogues: structural and conformational requirements for immunosuppressive activity. Wenger RM Prog Allergy; 1986; 38():46-64. PubMed ID: 3725755 [No Abstract] [Full Text] [Related]
3. Cyclosporine: conformation and analogues as tools for studying its mechanism of action. Wenger RM Transplant Proc; 1988 Apr; 20(2 Suppl 2):313-8. PubMed ID: 3363641 [No Abstract] [Full Text] [Related]
4. Cyclosporins. Structure-activity relationships. Fliri H; Baumann G; Enz A; Kallen J; Luyten M; Mikol V; Movva R; Quesniaux V; Schreier M; Walkinshaw M Ann N Y Acad Sci; 1993 Nov; 696():47-53. PubMed ID: 8109856 [TBL] [Abstract][Full Text] [Related]
5. Cyclosporine and analogues--isolation and synthesis--mechanism of action and structural requirements for pharmacological activity. Wenger RM Fortschr Chem Org Naturst; 1986; 50():123-36. PubMed ID: 3546034 [No Abstract] [Full Text] [Related]
6. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture. Cole E; Skorecki K; Cheung F; Wong PY; Fung LS; Levy GA Transplant Proc; 1988 Jun; 20(3 Suppl 3):732-7. PubMed ID: 3388511 [No Abstract] [Full Text] [Related]
7. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine. Hiestand PC; Gunn HC; Gale JM; Ryffel B; Borel JF Immunology; 1985 Jun; 55(2):249-55. PubMed ID: 3891595 [TBL] [Abstract][Full Text] [Related]
8. The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines. Langman LJ; Yatscoff RW Transplant Proc; 1994 Oct; 26(5):3002-5. PubMed ID: 7940948 [No Abstract] [Full Text] [Related]
9. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity. Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and identification of novel colchicine-derived immunosuppressant. Chang DJ; Yoon EY; Lee GB; Kim SO; Kim WJ; Kim YM; Jung JW; An H; Suh YG Bioorg Med Chem Lett; 2009 Aug; 19(15):4416-20. PubMed ID: 19502058 [TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine and some derivatives on chronic rejection. Lu X; Dawson J; Borel JF Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221 [No Abstract] [Full Text] [Related]
12. New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation. Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Donatsch P; Ryffel B; Borel JF Transplant Proc; 1993 Feb; 25(1 Pt 1):691-2. PubMed ID: 8438439 [No Abstract] [Full Text] [Related]